Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan antes up $90M in a CRISPR/Cas9 collaboration with Editas on eye diseases
Allergan antes up $90M in a CRISPR/Cas9 collaboration with Editas on eye diseases
Allergan antes up $90M in a CRISPR/Cas9 collaboration with Editas on eye diseases
Submitted by
admin
on March 14, 2017 - 9:42am
Source:
Endpoints
News Tags:
Allergan
eye health
CRISPR-Cas9
Editas
Headline:
Allergan antes up $90M in a CRISPR/Cas9 collaboration with Editas on eye diseases
Do Not Allow Advertisers to Use My Personal information